This site streams its live parts over a connection JavaScript opens — search, the timeline, and anything that updates while you watch. With JavaScript off you get the words, which is most of it, and none of the moving parts.
Roth et al report (NEJM) on sutimlimab monotherapy (CARDINAL) (nonrandomized)
Roth et al report (Blood) on sutimlimab monotherapy (CADENZA) (phase III placebo-controlled RCT)
